Capsule Based Dry Powder Inhalation: A Holistic Approach for Effective Pulmonary Drug Delivery

Sponsored by: ACG Worldwide

Focused on:

  • Inhalation
  • Respiratory Therapy
  • Dpi Capsules

Date: 9 November


Time: 3PM London/10AM New York

Comprehensive solution for cDPI: opportunities, trends and possibilities

Inhalation delivery has gained wide acceptance as an effective non-invasive method for local and systemic therapeutic delivery of active pharmaceutical ingredients (APIs). This is due to the unique features of the lungs displaying a large surface area, thin alveolar capillary membrane, low enzymatic activity and avoidance of first pass metabolism.

One of the most used platforms in this technology are capsule based dry powder inhalation (cDPI). This webinar explains from a scientific standpoint why they are interesting within the pharmaceutical community.

The webinar will provide a comprehensive overview of the benefits of capsules in DPIs. It will consider various aspects of cDPI and deliver a state of the art review of the technology and solution available from ACG. It will showcase how ACG’s holistic approach to DPIs as a delivery system enables customers to take advantage of our science and engineering capabilities.

Presented by

Fernando Diez,

Scientific Business Development Manager – ACG Worldwide

Fernando Diez holds a degree in chemistry followed by an MBA. He is responsible for creating new business opportunities outside of the formal review/tender process and collaborate with external researching institutes and R&D centres. Major part of his career was dedciated to pharmaceutical industry and have worked with renowned multi-national companies in past.

Justin Kalafat,

Business Development Manager - ACG North America

Justin Kalafat is responsible for collaborating with pharmaceutical industry for capsule business. Prior to joining ACG in 2014, his background includes degrees in chemistry and roles within the generic pharmaceutical industry in quality control and procurement. His experiences enable key strategies to be developed with customers, R&D focused institutions and universities on the technical aspects of capsules as a dosage form solution.

Key Learning Objectives

  • Opportunities in respiratory disease / target therapies and cDPI market trends
  • Summary of various inhalation technologies and advances
  • DPI as preferred solution for respiratory therapy
  • Ideal capsules for dry powder inhalation
  • Essential cDPI considerations for manufacturers to scale up


  • Research & Development professionals
  • Product Management professionals (Respiratory Products Portfolio)
  • Marketing professionals
  • Quality Management professionals
  • Production Heads
  • Supply Chain / Purchase / Procurement professionals